It has been reported that antibodies against CTLA-4 (anti-CTLA-4) induce proliferation of TCR-stimulated T effector cells and abrogate Treg suppressive activity by enhancing IL-2 and IFNγ release in response to polyclonal or tumor antigen stimulation [16]. This evidence concerns the gene CTLA4 and neoplasm.